| Christa Wilson, PHARMD | |
|
1721 Saemann Ave, Sheboygan, WI 53081-2342 | |
| (920) 783-6633 | |
| Not Available |
| Full Name | Christa Wilson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1721 Saemann Ave, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043733447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1886940 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christa Wilson, PHARMD Po Box 959, Sheboygan, WI 53082-0959 Ph: (920) 783-6633 | Christa Wilson, PHARMD 1721 Saemann Ave, Sheboygan, WI 53081-2342 Ph: (920) 783-6633 |
News Archive
Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have identified an experimental agent that targets chronic lymphocytic leukemia and perhaps other proliferative disorders of lymphocytes.
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).
HHS should include patient characteristics such as race and limited English proficiency in its risk-adjustment methodology as it implements the hospital readmissions-reduction program outlined in the healthcare reform law, according to a letter Tuesday from American Hospital Association President and CEO Richard Umbdenstock to CMS Administrator Dr. Donald Berwick.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a drug derived from a naturally occurring human protein, a new animal study suggests.
› Verified 7 days ago
Mr. Lawrence J Mihalevich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 | |
Mary Miller, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1317 N 25th St, Picknsave Pharmacy 6432, Sheboygan, WI 53081 Phone: 920-457-5839 Fax: 920-457-5853 | |
Judith L Lukach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Matthew Wilke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Dr. David Roth, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 N 14th St, Sheboygan, WI 53081 Phone: 920-452-0079 | |
Tou Lee Xiong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 |